| UHC Medicaid Medical & Drug | Sinus Surgeries and Interventions – Community Plan Medical Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Skin and Soft Tissue Substitutes – Community Plan Medical Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Skyrizi® (Risankizumab-Rzaa) – Community Plan Medical Benefit Drug Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins – Community Plan Medical Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Transcatheter Procedures for Heart Valve Conditions – Community Plan Medical Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Tzield® (Teplizumab-Mzwv) – Community Plan Medical Benefit Drug Policy | 2026-08-01 |
| UHC Medicaid Medical & Drug | Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) – Community Plan Medical Policy | 2026-08-01 |
| Sentara Health Plans Avalon | F2019: Flow Cytometry | 2026-08-01 |
| Sentara Health Plans Avalon | G2008: Prostate Specific Antigen (PSA) Testing | 2026-08-01 |
| Sentara Health Plans Avalon | G2022: Biomarker Testing for Autoimmune Rheumatic Disease | 2026-08-01 |